Boston Scientific Shares Drop 5% Despite Strong Undervaluation Signals

Boston Scientific Corp (BSX) shares declined 5.0%, widening the gap with its estimated fair value of $104.44. Similarly, DexCom Inc (DXCM) shares fell 3.1% to $62.60, trading at a significant 42.7% discount to its GF Value, while Cencora Inc (COR) dropped 3.3% but remains 8.2% overvalued. Contrasting this trend, NetApp Inc (NTAP) shares rose 4.7% to $111.80, bringing the stock within 1.9% of its fair value estimate. However, insider activity remains a point of caution across these sectors, with DXCM, NTAP, and COR reporting a combined $2.2 million in insider selling and zero buying activity. This divergence highlights a broader trend where intrinsic value signals are often countered by immediate technical pressures and persistent insider liquidations.